Self-nanoemulsifying drug delivery system (SNEDDS) of piroxicam: evaluation on anti-inflammantory activity in wistar rats

Authors

  • Yudha Rizky Nuari Faculty of Pharmacy, Universitas Ahmad Dahlan
  • Iis Wahyuningsih Faculty of Pharmacy, Universitas Ahmad Dahlan
  • Sekar Prabawati Faculty of Pharmacy, Universitas Ahmad Dahlan

DOI:

https://doi.org/10.12928/pharmaciana.v11i2.20973

Keywords:

SNEDDS, piroxicam, anti-inflammatory

Abstract

Piroxicam is a non-steroidal anti-inflammatory drug (NSAID) that is commonly used for arthritis, gout, and other musculoskeletal disorders. Piroxicam is poorly soluble in water and according to the biopharmaceutical drug classification system (BCS) is classified as a Class II drug with good permeability but poor dissolution. The self-nanoemulsifying drug delivery system (SNEDDS) has been extensively employed to improve the dissolution and absorption of water-insoluble drugs within the gastrointestinal tract, leading to enhanced oral bioavailability and increased therapeutic effect of the loaded drugs. Therefore, the present study aims to evaluate the anti-inflammatory activity of piroxicam-loaded SNEDDS as compared to conventional piroxicam suspension that was observed in male Wistar strain rats. The SNEDDS was tailored from a mixture of oleic acid, tween 80, and propylene glycol. Twenty male Wistar strain rats (aged 2-3 months, weighed 150-250g) were selected and were divided equally into 4 different groups receiving 1% PVP, SNEDDS carrier, piroxicam suspension (1.8 mg/Kg BW), and SNEDDS piroxicam (1.8 mg/Kg BW). Acute inflammation was induced by a carrageenan-induced paw edema model where the carrageenan was injected sub plantar in the hind paw of the rats to induce edema. Several parameters including paw edema volume, AUC0-6, and percent anti-inflammatory effect, were measured to evaluate the anti-inflammatory activity experienced in each group. At the end of this study, the piroxicam SNEDDS group significantly demonstrated better protection from paw edema compared to the piroxicam suspension group (Ï<0.05), suggesting that SNEDDS may enhance the anti-inflammatory activity of piroxicam.

References

Abd-Allah, F. I., Dawaba, H. M., & Ahmed, A. M. (2010). Development of a microemulsion-based formulation to improve the availability of poorly water-soluble drug. Drug Discoveries & Therapeutics, 4(4), 257–266

Balakumar, K., Raghavan, C. V., selvan, N. T., prasad, R. H., & Abdu, S. (2013). Self Nanoemulsifying Drug Delivery System (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation. Colloids and Surfaces. B, Biointerfaces, 112, 337–343. https://doi.org/10.1016/j.colsurfb.2013.08.025

Baloch, J., Sohail, M. F., Sarwar, H. S., Kiani, M. H., Khan, G. M., Jahan, S., Rafay, M., Chaudhry, M. T., Yasinzai, M., & Shahnaz, G. (2019). Self-Nanoemulsifying Drug Delivery System (SNEDDS) for improved oral bioavailability of chlorpromazine: in vitro and in vivo evaluation. Medicina (Kaunas, Lithuania), 55(5). https://doi.org/10.3390/medicina55050210

Barzegar-Jalali, M., Ghanbarzadeh, S., Adibkia, K., Valizadeh, H., Bibak, S., Mohammadi, G., & Siahi-Shadbad, M. R. (2014). Development and characterization of solid dispersion of piroxicam for improvement of dissolution rate using hydrophilic carriers. BioImpacts : BI, 4(3), 141–148. https://doi.org/10.15171/bi.2014.007

Belhadj, Z., Zhang, S., Zhang, W., & Wang, J. (2013). Formulation development and bioavailability evaluation of a Self-Nanoemulsifying Drug Delivery System (SNEDDS) of atorvastatin calcium. Int J Pharm, 1, 1103–1113

Buya, A. B., Beloqui, A., Memvanga, P. B., & Préat, V. (2020). Self-Nano-Emulsifying Drug-Delivery Systems: from the development to the current applications and challenges in oral drug delivery. Pharmaceutics, 12(12). https://doi.org/10.3390/pharmaceutics12121194

Cherniakov, I., Domb, A. J., & Hoffman, A. (2015). Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects. Expert Opinion on Drug Delivery, 12(7), 1121–1133. https://doi.org/10.1517/17425247.2015.999038

Cong, H. H., Khaziakhmetova, V. N., & Zigashina, L. E. (2015). Rat paw oedema modeling and NSAIDs: Timing of effects. The International Journal of Risk & Safety in Medicine, 27 Suppl 1, S76-7. https://doi.org/10.3233/JRS-150697

Hapsari, R. D., Bagiana, I. K., & Herlyanti, K. (2016). Perbandingan aktivitas antiinflamasi ekstrak etanol daun sidaguri (Sida rhombifolia L.) dalam sediaan Self-Nano Emulsifying Drug Delivery System (SNEDDS) dan suspensi pada tikus putih jantan. Media Farmasi Indonesia, 11(1)

Hussain, A., Farrukh, M., Abbas, N., Irfan, M., Arshad, M. S., & Bukhari, N. I. (2019). Effect of low melting hydrophilic carriers on the solubility and dissolution rate of piroxicam using solid dispersion technique. Pakistan Journal of Pharmaceutical Sciences, 32(5(Supplementary)), 2257–2260

Jannin, V., Chevrier, S., Michenaud, M., Dumont, C., Belotti, S., Chavant, Y., & Demarne, F. (2015). Development of self emulsifying lipid formulations of BCS class II drugs with low to medium lipophilicity. International Journal of Pharmaceutics, 495(1), 385–392. https://doi.org/10.1016/j.ijpharm.2015.09.009

Kanwal, T., Kawish, M., Maharjan, R., Ghaffar, I., Ali, H. S., Imran, M., Perveen, S., Saifullah, S., Simjee, S. U., & Shah, M. R. (2019). Design and development of permeation enhancer containing self-nanoemulsifying drug delivery system (SNEDDS) for ceftriaxone sodium improved oral pharmacokinetics. Journal of Molecular Liquids, 289, 111098. https://doi.org/https://doi.org/10.1016/j.molliq.2019.111098

Ke, Z., Hou, X., & Jia, X.-B. (2016). Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D. Drug Design, Development and Therapy, 10, 2049–2060. https://doi.org/10.2147/DDDT.S106356

Makadia, H. A., Bhatt, A. Y., Parmar, R. B., Paun, J. S., & Tank, H. M. (2013). Self-nano Emulsifying Drug Delivery System (SNEDDS): Future Aspects. Asian Journal of Pharmaceutical Research, 3(1), 20–26

Mansouri, M. T., Hemmati, A. A., Naghizadeh, B., Mard, S. A., Rezaie, A., & Ghorbanzadeh, B. (2015). A study of the mechanisms underlying the anti-inflammatory effect of ellagic acid in carrageenan-induced paw edema in rats. Indian Journal of Pharmacology, 47(3), 292–298. https://doi.org/10.4103/0253-7613.157127

Mirza, S., Miroshnyk, I., Habib, M. J., Brausch, J. F., & Hussain, M. D. (2010). Enhanced dissolution and oral bioavailability of piroxicam formulations: modulating effect of phospholipids. Pharmaceutics, 2(4), 339–350. https://doi.org/10.3390/pharmaceutics2040339

Mohsin, K., Alamri, R., Ahmad, A., Raish, M., Alanazi, F. K., & Hussain, M. D. (2016). Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug. International Journal of Nanomedicine, 11, 2829–2838. https://doi.org/10.2147/IJN.S104187

Motawea, A., Borg, T., Tarshoby, M., & Abd El-Gawad, A. E.-G. H. (2017). Nanoemulsifying drug delivery system to improve the bioavailability of piroxicam. Pharmaceutical Development and Technology, 22(3), 445–456. https://doi.org/10.1080/10837450.2016.1231810

Obitte, N. C., Rohan, L. C., Adeyeye, C. M., Parniak, M. A., & Esimone, C. O. (2013). The utility of self-emulsifying oil formulation to improve the poor solubility of the anti HIV drug CSIC. AIDS Research and Therapy, 10(1), 14. https://doi.org/10.1186/1742-6405-10-14

Otarola, J., Lista, A. G., Fernández Band, B., & Garrido, M. (2015). Capillary electrophoresis to determine entrapment efficiency of a nanostructured lipid carrier loaded with piroxicam. Journal of Pharmaceutical Analysis, 5(1), 70–73. https://doi.org/10.1016/j.jpha.2014.05.003

Abd-Allah, F. I., Dawaba, H. M., & Ahmed, A. M. (2010). Development of a microemulsion-based formulation to improve the availability of poorly water-soluble drug. Drug Discoveries & Therapeutics, 4(4), 257–266

Balakumar, K., Raghavan, C. V., selvan, N. T., prasad, R. H., & Abdu, S. (2013). Self Nanoemulsifying Drug Delivery System (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation. Colloids and Surfaces. B, Biointerfaces, 112, 337–343. https://doi.org/10.1016/j.colsurfb.2013.08.025

Baloch, J., Sohail, M. F., Sarwar, H. S., Kiani, M. H., Khan, G. M., Jahan, S., Rafay, M., Chaudhry, M. T., Yasinzai, M., & Shahnaz, G. (2019). Self-Nanoemulsifying Drug Delivery System (SNEDDS) for improved oral bioavailability of chlorpromazine: in vitro and in vivo evaluation. Medicina (Kaunas, Lithuania), 55(5). https://doi.org/10.3390/medicina55050210

Barzegar-Jalali, M., Ghanbarzadeh, S., Adibkia, K., Valizadeh, H., Bibak, S., Mohammadi, G., & Siahi-Shadbad, M. R. (2014). Development and characterization of solid dispersion of piroxicam for improvement of dissolution rate using hydrophilic carriers. BioImpacts : BI, 4(3), 141–148. https://doi.org/10.15171/bi.2014.007

Belhadj, Z., Zhang, S., Zhang, W., & Wang, J. (2013). Formulation development and bioavailability evaluation of a Self-Nanoemulsifying Drug Delivery System (SNEDDS) of atorvastatin calcium. Int J Pharm, 1, 1103–1113

Buya, A. B., Beloqui, A., Memvanga, P. B., & Préat, V. (2020). Self-Nano-Emulsifying Drug-Delivery Systems: from the development to the current applications and challenges in oral drug delivery. Pharmaceutics, 12(12). https://doi.org/10.3390/pharmaceutics12121194

Cherniakov, I., Domb, A. J., & Hoffman, A. (2015). Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects. Expert Opinion on Drug Delivery, 12(7), 1121–1133. https://doi.org/10.1517/17425247.2015.999038

Cong, H. H., Khaziakhmetova, V. N., & Zigashina, L. E. (2015). Rat paw oedema modeling and NSAIDs: Timing of effects. The International Journal of Risk & Safety in Medicine, 27 Suppl 1, S76-7. https://doi.org/10.3233/JRS-150697

Hapsari, R. D., Bagiana, I. K., & Herlyanti, K. (2016). Perbandingan aktivitas antiinflamasi ekstrak etanol daun sidaguri (Sida rhombifolia L.) dalam sediaan Self-Nano Emulsifying Drug Delivery System (SNEDDS) dan suspensi pada tikus putih jantan. Media Farmasi Indonesia, 11(1)

Hussain, A., Farrukh, M., Abbas, N., Irfan, M., Arshad, M. S., & Bukhari, N. I. (2019). Effect of low melting hydrophilic carriers on the solubility and dissolution rate of piroxicam using solid dispersion technique. Pakistan Journal of Pharmaceutical Sciences, 32(5(Supplementary)), 2257–2260

Jannin, V., Chevrier, S., Michenaud, M., Dumont, C., Belotti, S., Chavant, Y., & Demarne, F. (2015). Development of self emulsifying lipid formulations of BCS class II drugs with low to medium lipophilicity. International Journal of Pharmaceutics, 495(1), 385–392. https://doi.org/10.1016/j.ijpharm.2015.09.009

Kanwal, T., Kawish, M., Maharjan, R., Ghaffar, I., Ali, H. S., Imran, M., Perveen, S., Saifullah, S., Simjee, S. U., & Shah, M. R. (2019). Design and development of permeation enhancer containing self-nanoemulsifying drug delivery system (SNEDDS) for ceftriaxone sodium improved oral pharmacokinetics. Journal of Molecular Liquids, 289, 111098. https://doi.org/https://doi.org/10.1016/j.molliq.2019.111098

Ke, Z., Hou, X., & Jia, X.-B. (2016). Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D. Drug Design, Development and Therapy, 10, 2049–2060. https://doi.org/10.2147/DDDT.S106356

Makadia, H. A., Bhatt, A. Y., Parmar, R. B., Paun, J. S., & Tank, H. M. (2013). Self-nano Emulsifying Drug Delivery System (SNEDDS): Future Aspects. Asian Journal of Pharmaceutical Research, 3(1), 20–26

Mansouri, M. T., Hemmati, A. A., Naghizadeh, B., Mard, S. A., Rezaie, A., & Ghorbanzadeh, B. (2015). A study of the mechanisms underlying the anti-inflammatory effect of ellagic acid in carrageenan-induced paw edema in rats. Indian Journal of Pharmacology, 47(3), 292–298. https://doi.org/10.4103/0253-7613.157127

Mirza, S., Miroshnyk, I., Habib, M. J., Brausch, J. F., & Hussain, M. D. (2010). Enhanced dissolution and oral bioavailability of piroxicam formulations: modulating effect of phospholipids. Pharmaceutics, 2(4), 339–350. https://doi.org/10.3390/pharmaceutics2040339

Mohsin, K., Alamri, R., Ahmad, A., Raish, M., Alanazi, F. K., & Hussain, M. D. (2016). Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug. International Journal of Nanomedicine, 11, 2829–2838. https://doi.org/10.2147/IJN.S104187

Motawea, A., Borg, T., Tarshoby, M., & Abd El-Gawad, A. E.-G. H. (2017). Nanoemulsifying drug delivery system to improve the bioavailability of piroxicam. Pharmaceutical Development and Technology, 22(3), 445–456. https://doi.org/10.1080/10837450.2016.1231810

Obitte, N. C., Rohan, L. C., Adeyeye, C. M., Parniak, M. A., & Esimone, C. O. (2013). The utility of self-emulsifying oil formulation to improve the poor solubility of the anti HIV drug CSIC. AIDS Research and Therapy, 10(1), 14. https://doi.org/10.1186/1742-6405-10-14

Otarola, J., Lista, A. G., Fernández Band, B., & Garrido, M. (2015). Capillary electrophoresis to determine entrapment efficiency of a nanostructured lipid carrier loaded with piroxicam. Journal of Pharmaceutical Analysis, 5(1), 70–73. https://doi.org/10.1016/j.jpha.2014.05.003

Patel, J., Kevin, G., Patel, A., Raval, M., & Sheth, N. (2011). Design and development of a self-nanoemulsifying drug delivery system for telmisartan for oral drug delivery. International Journal of Pharmaceutical Investigation, 1(2), 112-118. https://doi.org/10.4103/2230-973X.82431

Rehman, F. U., Shah, K. U., Shah, S. U., Khan, I. U., Khan, G. M., & Khan, A. (2017). From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS). Expert Opinion on Drug Delivery, 14(11), 1325–1340. https://doi.org/10.1080/17425247.2016.1218462

Sahlan, M., Devina, A., Pratami, D. K., Situmorang, H., Farida, S., Munim, A., Kusumoputro, B., Yohda, M., Faried, A., Gozan, M., & Ledyawati, M. (2019). Anti-inflammatory activity of Tetragronula species from Indonesia. Saudi Journal of Biological Sciences, 26(7), 1531–1538. https://doi.org/https://doi.org/10.1016/j.sjbs.2018.12.008

Wilmana, P. F., & Gunawan, S. G. (2007). Analgesik-antipiretik, analgesik anti-inflamasi non steroid dan obat gangguan sendi lainnya (V). Bagian Farmakologi Fakultas Kedokteran, Universitas Indonesia Jakarta

Yang, M., Gong, W., Wang, Y., Shan, L., Li, Y., & Gao, C. (2016). Bioavailability Improvement Strategies for Poorly Water-Soluble Drugs Based on the Supersaturation Mechanism: An Update. Journal of Pharmacy & Pharmaceutical Sciences : A Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques, 19(2), 208–225. https://doi.org/10.18433/J3W904

Zaerosa, N. F. (2016). Pengembangan Self-nano emulsifying drug delivery system (SNEDDS) piroksikam menggunakan fase minyak asam oleat.Skripsi, Fakultas Farmasi Universitas Ahmad Dahlan, Yogyakarta

Downloads

Published

2021-07-30

Issue

Vol. 11 No. 2 (2021): Pharmaciana

Section

Pharmacology

License

Authors who publish with Pharmaciana agree to the following terms:

  1. Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.